Biology, Therapeutics, and Prophylaxis in Recurrent Depression
Affective disorders constitute the most common major psychiatric problem. While even a single episode of depression is disabling and entails considerable economic cost and personal suffering, recurrent depression represents a major public health problem. The identification and succesful treatment of individuals who develop repeated episodes of depression have become high clinical priorities.
KeywordsPlacebo Depression Lithium Cortisol Tricyclic
Unable to display preview. Download preview PDF.
- Frank E, Kupfer DJ (1985). Maintenance treatment of recurrent unipolar depression: pharmacology and psychotherapy. In: Costa E, Racagni G, Kemali D (eds) Chronic treatments in neuropsychiatry. Raven, New York, pp 139–151.Google Scholar
- Frank E, Jarrett DB, Kupfer DJ, Grochocinski VJ (1984) Biological and clinical predictors of response in recurrent depression. A preliminary report. Psychiatry Res 13:314, 5-32Google Scholar
- Jarrett DB, Coble PA, Kupfer DJ (1985) Cortisol secretion during sleep in patients with severe depression. In: Kathol R, Hall RC (eds) Psychiatric medicine. Spectrum, New York, pp 101–110.Google Scholar
- Klerman GL, Weissman MM, Rounsaville B, Chevron ES (1984) Interpersonal psychotherapy of depression. Basic Books, New York.Google Scholar
- Kupfer DJ, Berger PA, Conger JJ et al. (1985) NIMH/NIH Consensus Development Conference Statement. Mood disorders: pharmacologie prevention of recurrences. Am J Psychiatry 142:469–476.Google Scholar